183 related articles for article (PubMed ID: 22693587)
21. Inhibition of tumor suppressor protein p53-dependent transcription by a tetramerization domain peptide via hetero-oligomerization.
Wada J; Kamada R; Imagawa T; Chuman Y; Sakaguchi K
Bioorg Med Chem Lett; 2012 Apr; 22(8):2780-3. PubMed ID: 22429466
[TBL] [Abstract][Full Text] [Related]
22. Structural evolution of C-terminal domains in the p53 family.
Ou HD; Löhr F; Vogel V; Mäntele W; Dötsch V
EMBO J; 2007 Jul; 26(14):3463-73. PubMed ID: 17581633
[TBL] [Abstract][Full Text] [Related]
23. Thermodynamics of p53 binding to hdm2(1-126): effects of phosphorylation and p53 peptide length.
Lai Z; Auger KR; Manubay CM; Copeland RA
Arch Biochem Biophys; 2000 Sep; 381(2):278-84. PubMed ID: 11032416
[TBL] [Abstract][Full Text] [Related]
24. p53 oligomerization and DNA looping are linked with transcriptional activation.
Stenger JE; Tegtmeyer P; Mayr GA; Reed M; Wang Y; Wang P; Hough PV; Mastrangelo IA
EMBO J; 1994 Dec; 13(24):6011-20. PubMed ID: 7813439
[TBL] [Abstract][Full Text] [Related]
25. Structural changes in the C-terminus of Ca2+-bound rat S100B (beta beta) upon binding to a peptide derived from the C-terminal regulatory domain of p53.
Rustandi RR; Baldisseri DM; Drohat AC; Weber DJ
Protein Sci; 1999 Sep; 8(9):1743-51. PubMed ID: 10493575
[TBL] [Abstract][Full Text] [Related]
26. Structure of the negative regulatory domain of p53 bound to S100B(betabeta).
Rustandi RR; Baldisseri DM; Weber DJ
Nat Struct Biol; 2000 Jul; 7(7):570-4. PubMed ID: 10876243
[TBL] [Abstract][Full Text] [Related]
27. Latent and active p53 are identical in conformation.
Ayed A; Mulder FA; Yi GS; Lu Y; Kay LE; Arrowsmith CH
Nat Struct Biol; 2001 Sep; 8(9):756-60. PubMed ID: 11524676
[TBL] [Abstract][Full Text] [Related]
28. Cooperative binding of tetrameric p53 to DNA.
Weinberg RL; Veprintsev DB; Fersht AR
J Mol Biol; 2004 Aug; 341(5):1145-59. PubMed ID: 15321712
[TBL] [Abstract][Full Text] [Related]
29. Structural basis of competitive recognition of p53 and MDM2 by HAUSP/USP7: implications for the regulation of the p53-MDM2 pathway.
Hu M; Gu L; Li M; Jeffrey PD; Gu W; Shi Y
PLoS Biol; 2006 Feb; 4(2):e27. PubMed ID: 16402859
[TBL] [Abstract][Full Text] [Related]
30. p53 domains: structure, oligomerization, and transformation.
Wang P; Reed M; Wang Y; Mayr G; Stenger JE; Anderson ME; Schwedes JF; Tegtmeyer P
Mol Cell Biol; 1994 Aug; 14(8):5182-91. PubMed ID: 8035799
[TBL] [Abstract][Full Text] [Related]
31. Formation of disulfide bond in p53 correlates with inhibition of DNA binding and tetramerization.
Sun XZ; Vinci C; Makmura L; Han S; Tran D; Nguyen J; Hamann M; Grazziani S; Sheppard S; Gutova M; Zhou F; Thomas J; Momand J
Antioxid Redox Signal; 2003 Oct; 5(5):655-65. PubMed ID: 14580323
[TBL] [Abstract][Full Text] [Related]
32. Stimulation of p53 DNA binding by c-Abl requires the p53 C terminus and tetramerization.
Nie Y; Li HH; Bula CM; Liu X
Mol Cell Biol; 2000 Feb; 20(3):741-8. PubMed ID: 10629029
[TBL] [Abstract][Full Text] [Related]
33. Two distinct motifs within the p53 transactivation domain bind to the Taz2 domain of p300 and are differentially affected by phosphorylation.
Jenkins LM; Yamaguchi H; Hayashi R; Cherry S; Tropea JE; Miller M; Wlodawer A; Appella E; Mazur SJ
Biochemistry; 2009 Feb; 48(6):1244-55. PubMed ID: 19166313
[TBL] [Abstract][Full Text] [Related]
34. Domain-domain interactions in full-length p53 and a specific DNA complex probed by methyl NMR spectroscopy.
Bista M; Freund SM; Fersht AR
Proc Natl Acad Sci U S A; 2012 Sep; 109(39):15752-6. PubMed ID: 22972749
[TBL] [Abstract][Full Text] [Related]
35. Allosteric effects mediate CHK2 phosphorylation of the p53 transactivation domain.
Craig A; Scott M; Burch L; Smith G; Ball K; Hupp T
EMBO Rep; 2003 Aug; 4(8):787-92. PubMed ID: 12897801
[TBL] [Abstract][Full Text] [Related]
36. Multiple conformations of full-length p53 detected with single-molecule fluorescence resonance energy transfer.
Huang F; Rajagopalan S; Settanni G; Marsh RJ; Armoogum DA; Nicolaou N; Bain AJ; Lerner E; Haas E; Ying L; Fersht AR
Proc Natl Acad Sci U S A; 2009 Dec; 106(49):20758-63. PubMed ID: 19933326
[TBL] [Abstract][Full Text] [Related]
37. Structure of the p53 C-terminus bound to 14-3-3: implications for stabilization of the p53 tetramer.
Schumacher B; Mondry J; Thiel P; Weyand M; Ottmann C
FEBS Lett; 2010 Apr; 584(8):1443-8. PubMed ID: 20206173
[TBL] [Abstract][Full Text] [Related]
38. Structural basis of DNA recognition by p53 tetramers.
Kitayner M; Rozenberg H; Kessler N; Rabinovich D; Shaulov L; Haran TE; Shakked Z
Mol Cell; 2006 Jun; 22(6):741-753. PubMed ID: 16793544
[TBL] [Abstract][Full Text] [Related]
39. Solvent-exposed residues located in the beta-sheet modulate the stability of the tetramerization domain of p53--a structural and combinatorial approach.
Mora P; Carbajo RJ; Pineda-Lucena A; Sánchez del Pino MM; Pérez-Payá E
Proteins; 2008 Jun; 71(4):1670-85. PubMed ID: 18076077
[TBL] [Abstract][Full Text] [Related]
40. Structural investigations of the p53/p73 homologs from the tunicate species Ciona intestinalis reveal the sequence requirements for the formation of a tetramerization domain.
Heering J; Jonker HR; Löhr F; Schwalbe H; Dötsch V
Protein Sci; 2016 Feb; 25(2):410-22. PubMed ID: 26473758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
